SLC16A1 and neoplasm: However, the mechanistic basis for this motility-promoting and -inhibiting effect by AVA and CHC-based protocols in MDA-MB231 tumor grafts must fundamentally differ from the metabolic symbiont concept [28] because the lactate importer MCT1 is absent in MDA-MB231 cells due to hypermethylation-mediated gene silencing [28].